GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
33.60
+0.17 (0.51%)
Dec 20, 2024, 4:00 PM EST - Market closed
GSK Revenue
GSK had revenue of 8.01B GBP in the quarter ending September 30, 2024, a decrease of -1.66%. This brings the company's revenue in the last twelve months to 31.31B, up 5.59% year-over-year. In the year 2023, GSK had annual revenue of 30.33B with 3.42% growth.
Revenue (ttm)
31.31B GBP
Revenue Growth
+5.59%
P/S Ratio
n/a
Revenue / Employee
445,949 GBP
Employees
70,212
Market Cap
67.72B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
Dec 31, 2019 | 33.75B | 2.93B | 9.52% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CVS Health | 367.25B |
McKesson | 330.19B |
Cencora | 293.96B |
The Cigna Group | 229.75B |
HCA Healthcare | 69.62B |
Becton, Dickinson and Company | 20.18B |
Haleon | 15.07B |
Regeneron Pharmaceuticals | 13.85B |
GSK News
- 1 day ago - GSK's cancer drugs meet progression-free survival goal in late-stage trial - Reuters
- 11 days ago - Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis - GlobeNewsWire
- 12 days ago - GSK's drug combo shown to cut risk of death by 42% in type of blood cancer - Reuters
- 16 days ago - GSK, China's Zhifei Expand Shingles Shot Collaboration - WSJ
- 16 days ago - GSK expands deal with China's Zhifei to explore RSV vaccine collaboration - Reuters
- 4 weeks ago - GSK's RSV vaccine gets Japan approval for adults aged 50 to 59 - Reuters
- 4 weeks ago - GSK share price is imploding: is it safe to buy the dip? - Invezz
- 4 weeks ago - GSK drug meets main goal in late-stage study to treat relentless itch - Reuters